OR WAIT null SECS
© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
September 17, 2021
An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.
September 06, 2021
Lack of antibodies from vaccination mainly affects patients with B cell cancers. Experts say antibodies are just one piece of the puzzle and that other aspects of the immune system fend off serious cases of COVID-19.
August 13, 2021
The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.
August 10, 2021
NCCN adds Rylaze to guidelines soon after was approved by the FDA and a British company reports positive results for its CAR-T therapy.
July 07, 2021
New research and updated treatment guidelines add to knowledge base on this rare blood cancer.
July 06, 2021
The Leukemia & Lymphoma Society is providing grants to increase trial enrollment of ethnic and racial minorities.
June 07, 2021
Researchers are making progress in identifying drugs that target certain mutations.
June 06, 2021
Phase 1b results show manageable toxicities with Venclexta and Rydapt.
June 02, 2021
NCCN recommends Brukinsa for CLL/SLL even though it is FDA-approved for mantel cell lymphoma.
January 20, 2021
Deposing the ‘Emperor of All Maladies’ will take a diverse toolkit, not a single moonshot.